Filing Details
- Accession Number:
- 0001140361-10-038308
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-09-22 19:07:54
- Reporting Period:
- 2010-09-20
- Filing Date:
- 2010-09-22
- Accepted Time:
- 2010-09-22 19:07:54
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
885988 | Integramed America Inc | INMD | Services-Offices & Clinics Of Doctors Of Medicine (8011) | 061150326 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1311443 | Blueline Partners, L.l.c. | 319 Diablo Road Ste 200 Danville CA 94526 | No | No | Yes | No | |
1338149 | Blueline Capital Partners, L.p. | 319 Diablo Road Ste 200 Danville CA 94526 | No | No | Yes | No | |
1411986 | Blueline Capital Partners Iii, Lp | 319 Diablo Road Ste 200 Danville CA 94526 | No | No | Yes | No | |
1411987 | Blueline Partners Ii, Llc | 319 Diablo Road Ste 200 Danville CA 94526 | No | No | Yes | No | |
1453017 | Blue Tsv I, Ltd. | C/O Maples Corporate Services Limited Po Box 309, Ugland House Grand Cayman E9 KY1-1104 | No | No | Yes | No | |
1460518 | Blueline Catalyst Fund Ix, L.p. | 319 Diablo Road Suite 200 Danville CA 94526 | No | No | Yes | No | |
1460781 | Blueline Capital Partners Ii, L.p. | 319 Diablo Road Ste 200 Danville CA 94526 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2010-09-20 | 8,454 | $9.03 | 1,282,509 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- As described in the Schedule 13D filing made on January 2, 2009 with respect to the Common Stock owned by BlueLine Capital Partners, L.P., BlueLine Capital Partners II, L.P., BlueLine Capital Partners III, L.P., BlueLine Catalyst Fund IX, L.P., BlueLine Partners, L.L.C., BlueLine Partners II, L.L.C., and Blue TSV I, LTD, the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock.The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, any Reporting Person is the beneficial owner of any Common Stock covered by this statement.